Momenta Pharmaceuticals Inc: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2007-12-25

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs. The company is applying its integrated analytical technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    Momenta Pharmaceuticals's is focused on the development of generic and novel drugs. The company has developed an integrated technology solution that addresses many of the challenges associated with creating drugs based on complex sugars.

    It currently has investigational compounds in clinical development for a wide range of diseases, including acute coronary syndrome, thrombosis, multiple sclerosis and cancer. In addition, the company has entered into collaboration with Sandoz for the joint development, manufacture and commercialization of certain of these compounds.

    Momenta Pharmaceuticals derives 100% of its revenues under collaboration and licensing agreement with Sandoz. During the period 2003-2006, the company's total revenues increased from $1 million to $16 million. Prior to 2003, the company did not record any revenues, as its collaboration agreement with Sandoz commenced only in 2003.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: momenta pharmaceuticals email enoxaparin profiling comporate brugger content sandoz company

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.